Investor Presentaiton

EBITDA Trend In INR Billion Sales 112 160 272 279 303 261 % of Sales 19% 17% 23% 25% 27% 28% 13% 14% 17% 16% 16% 21% 24% 25% 30% 33% 28% 31% 44% 44% 29% 27% 29% 20% FY13 FY14 FY15 FY16 FY17 FY18 EBITDA Other Expenditure Personnel Costs Material Costs © Sun Pharmaceutical Industries Limited. All Rights Reserved. SUN PHARMA 47

View entire presentation